BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17853253)

  • 1. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification.
    Mann K; Rothschild JM; Keohane CA; Chu JA; Bates DW
    World J Biol Psychiatry; 2008; 9(1):24-33. PubMed ID: 17853253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
    Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
    Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMSP drug safety program: methods and global results.
    Grohmann R; Engel RR; Rüther E; Hippius H
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and reducing medication errors in psychiatry: creating a culture of safety through the use of an adverse event reporting mechanism.
    Jayaram G; Doyle D; Steinwachs D; Samuels J
    J Psychiatr Pract; 2011 Mar; 17(2):81-8. PubMed ID: 21430486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug events in the elderly.
    Cresswell KM; Fernando B; McKinstry B; Sheikh A
    Br Med Bull; 2007; 83():259-74. PubMed ID: 17580312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac adverse effects associated with psychotropic drugs.
    Schmid C; Grohmann R; Engel RR; Rüther E; Kropp S
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk reduction for adverse drug events through sequential implementation of patient safety initiatives in a children's hospital.
    Leonard MS; Cimino M; Shaha S; McDougal S; Pilliod J; Brodsky L
    Pediatrics; 2006 Oct; 118(4):e1124-9. PubMed ID: 17015504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interception of potential adverse drug events in long-term psychiatric care units.
    Sawamura K; Ito H; Yamazumi S; Kurita H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):379-84. PubMed ID: 16048442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multidisciplinary approach to adverse drug events in pediatric trauma patients in an adult trauma center.
    Kalina M; Tinkoff G; Gleason W; Veneri P; Fulda G
    Pediatr Emerg Care; 2009 Jul; 25(7):444-6. PubMed ID: 19564808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood dyscrasias induced by psychotropic drugs.
    Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.
    Mills PD; Neily J; Kinney LM; Bagian J; Weeks WB
    Qual Saf Health Care; 2008 Feb; 17(1):37-46. PubMed ID: 18245218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric medication safety: the power of the team.
    Cahill M
    Nurs Adm Q; 2009; 33(1):38-47. PubMed ID: 19092522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial.
    Schnipper JL; Hamann C; Ndumele CD; Liang CL; Carty MG; Karson AS; Bhan I; Coley CM; Poon E; Turchin A; Labonville SA; Diedrichsen EK; Lipsitz S; Broverman CA; McCarthy P; Gandhi TK
    Arch Intern Med; 2009 Apr; 169(8):771-80. PubMed ID: 19398689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventable medication-related events in hospitalised children in New Zealand.
    Kunac DL; Reith DM
    N Z Med J; 2008 Apr; 121(1272):17-32. PubMed ID: 18425151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving safety for children with cardiac disease.
    Thiagarajan RR; Bird GL; Harrington K; Charpie JR; Ohye RC; Steven JM; Epstein M; Laussen PC
    Cardiol Young; 2007 Sep; 17 Suppl 2():127-32. PubMed ID: 18039406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Errors in the administration of intravenous medication in Brazilian hospitals.
    Anselmi ML; Peduzzi M; Dos Santos CB
    J Clin Nurs; 2007 Oct; 16(10):1839-47. PubMed ID: 17880472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.